AstraZeneca PLC is 126.1x more valuable than Vera Therapeutics, Inc. by market capitalization ($286.27 B vs $2.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VERA | AZN |
|---|---|---|
| Market cap | $2.27 B | $286.27 B |
| US-listed rank | #2012 | #45 |
| Net income (latest FY) | -$299.62M | - |
| SEC filings | 447 | 1,004 |
AstraZeneca PLC is 126.1x more valuable than Vera Therapeutics, Inc. by market capitalization ($286.27 B vs $2.27 B).
Full pages: Vera Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.